Ascendis Pharma A/S

(NASDAQ:ASND)

Latest On Ascendis Pharma A/S (ASND):

Date/Time Type Description Signal Details
2023-05-08 18:47 ESTNewsAscendis Pharma added to Wedbush's best ideas listN/A
2023-05-02 17:38 ESTNewsAscendis Pharma Q1 Earnings: Skytrofa Soars, PTH Hurdles Yet To ClearN/A
2023-05-01 17:06 ESTNewsAscendis' TransCon gets FDA rejection but company hopeful as no new trials requestedN/A
2023-04-28 02:05 ESTNewsAscendis Pharma A/S (ASND) Q1 2023 Earnings Call TranscriptN/A
2023-04-27 01:02 ESTNewsAscendis Pharma Q1 2023 Earnings PreviewN/A
2023-04-20 16:46 ESTNewsAscendis Pharma: A Promising Diversification PlayN/A
2023-04-17 01:29 ESTNewsAscendis Pharma: Recent FDA Setbacks Present A Buying OpportunityN/A
2023-04-06 23:12 ESTNewsAscendis Pharma: Is Dip On TransCon Application A Buy Opportunity?N/A
2023-04-03 14:24 ESTNewsAscendis stock slumps ~35% after FDA finds 'deficiencies' in TransCon applicationN/A
2023-04-03 14:24 ESTNewsAscendis downgraded at Credit Suisse on deficiencies in drug applicationN/A
2023-02-17 11:10 ESTNewsAscendis Pharma A/S (ASND) Q4 2022 Earnings Call TranscriptN/A
2023-02-16 22:05 ESTNewsAscendis Pharma GAAP EPS of -€10.40, revenue of €51.17MN/A
2023-02-15 19:21 ESTNewsAscendis Pharma FY 2022 Earnings PreviewN/A
2023-01-27 16:41 ESTNewsAscendis: Neutral On Skytrofa's Market Launch, Initiating With A Neutral RatingN/A
2023-01-19 02:12 ESTNewsAscendis Pharma: Group's Best Nearby Capital Gain Price-Position StockN/A
2022-11-17 14:37 ESTNewsAscendis, Visen' once-weekly growth hormone drug beats daily hGH in Chinese patients in trialN/A
2022-11-14 19:34 ESTNewsAscendis falls on Phase 2 data for achondroplasia candidateN/A
2022-11-05 05:43 ESTNewsAscendis Pharma A/S (ASND) Q3 2022 Earnings Call TranscriptN/A
2022-11-04 12:46 ESTNewsAscendis Pharma: Translating Valuable IP Into A Profitable BusinessN/A
2022-11-03 02:59 ESTNewsAscendis Pharma GAAP EPS of -€3.03, revenue of €15.29MN/A
2022-11-01 19:43 ESTNewsAscendis Pharma Q3 2022 Earnings PreviewN/A
2022-11-01 03:36 ESTNewsAscendis parathyroid hormone therapy goes under FDA priority reviewN/A
2022-09-16 02:59 ESTNewsAscendis Pharma: TransCon CNP Data Coming Q4N/A
2022-08-31 23:18 ESTNewsAscendis Pharma seeks FDA nod for its parathyroid hormone restorer TransCon PTHN/A
2022-08-11 20:08 ESTNewsAscendis Pharma Q2 results beat buoyed by strong sales of growth hormone drug SkytrofaN/A
2022-08-11 03:38 ESTNewsAscendis Pharma GAAP EPS of -€1.46 beats by €0.69, revenue of €6.16B beats by $6.15BN/A
2022-08-11 03:37 ESTNewsAscendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-10 09:43 ESTNewsAscendis Pharma Q2 2022 Earnings PreviewN/A
2022-08-04 05:34 ESTNewsAscendis Pharma: Institutional Buying Values Dutch Biotech Best-Now Cap-Gain ProspectN/A
2022-05-23 09:02 ESTNewsAscendis, Visen' TransCon hGH meets main goal in growth hormone deficiency China trial in childrenN/A
2022-05-13 04:45 ESTNewsAscendis Pharma slides after Street analysts cut price target over SKYTROFA revenue missN/A
2022-05-12 09:00 ESTNewsAscendis Pharma GAAP EPS of -€2.21 misses by €0.05, revenue of €6.83M beats by €1.98MN/A
2022-05-12 09:00 ESTNewsAscendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-10 19:27 ESTNewsAscendis Pharma Q1 2022 Earnings PreviewN/A
2022-05-09 22:24 ESTNewsAscendis Pharma: Biotech Bear Provides Attractive Entry PointN/A
2022-04-29 17:39 ESTNewsAscendis: Institutional Buying Activity Now Seen As Good Value By Market-MakersN/A
2022-03-25 08:03 ESTNewsAscendis Pharma prices $500.0M convertible senior notes offeringN/A
2022-03-23 22:32 ESTNewsAscendis Pharma slides on offering of $500M convertible senior notesN/A
2022-03-16 20:02 ESTNewsAscendis posts biggest intraday gain in six months as BofA upgrades on trial resultsN/A
2022-03-14 20:55 ESTNewsAscendis Pharma TransCon PTH for hypoparathyroidism meets main goal in phase 3 trialN/A
2022-03-03 04:55 ESTNewsAscendis Pharma GAAP EPS of $7.00 beats by €15.44, revenue of €7.77M misses by $0.13MN/A
2022-03-03 04:55 ESTNewsAscendis Pharma stock falls 7% despite Q4 bottom line beatN/A
2022-03-03 04:55 ESTNewsAscendis Pharma A/S' (ASND) CEO Jan Mikkelsen on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-01 18:03 ESTNewsAscendis Pharma FY Earnings PreviewN/A
2022-01-25 06:13 ESTNewsPfizer/OPKO loss on somatrogon could boost Ascendis Pharma's fortunesN/A
2022-01-24 14:23 ESTNewsAscendis Pharma (ASND) Presents At 40th Annual J.P. Morgan Virtual Healthcare ConferenceN/A
2022-01-24 14:23 ESTNewsPfizer/OPKO loss on somatragon could boost Ascendis Pharma's fortunesN/A
2022-01-14 01:12 ESTNewsAscendis Pharma's TransCon gets EU approval for growth hormone deficiency in childrenN/A
2021-12-30 05:41 ESTNewsAscendis: Danish Biotech With Thin Audience Now Seen As Good Value By Market-MakersN/A
2021-11-19 04:06 ESTNewsPhase 2 data shows durable response of Ascendis candidate for hypoparathyroidismN/A

About Ascendis Pharma A/S (ASND):

Ascendis Pharma A/S, a biopharmaceutical company, develops therapeutics for unmet medical needs. The company develops TransCon growth hormone, which completed Phase III clinical trials for growth hormone deficiency. It also develops TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for achondroplasia. In addition, the company develops preclinical studies in the field of oncology for potential product candidates and evaluate systemic and localized delivery systems using its TransCon technologies. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

See Advanced Chart

General

  • Name Ascendis Pharma A/S
  • Symbol ASND
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 482
  • Fiscal Year EndDecember
  • IPO Date2015-01-28
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.ascendispharma.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 917.83
  • Price/Book (Most Recent Quarter) 8.08
  • Enterprise Value Revenue 1052.08
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$8.67
  • Next Year EPS Estimate -$7.26
  • Next Quarter EPS Estimate -$2.01
  • Return on Assets -25%
  • Return on Equity -58%
  • Earnings Per Share -$5.09
  • Revenue Per Share $0
  • Gross Profit 6.95 million
  • Quarterly Earnings Growth -78.7%
View More

Highlights

  • Market Capitalization 7.87 billion
  • Analyst Target Price $194.63
  • Book Value Per Share $8.43
View More

Share Statistics

  • Shares Outstanding 53.75 million
  • Shares Float 43.76 million
  • % Held by Insiders 3%
  • % Held by Institutions 101.6%
  • Shares Short 2.48 million
  • Shares Short Prior Month 2.21 million
  • Short Ratio 11.66
  • Short % of Shares Outstanding 5%
View More

Technicals

  • Beta 0.79
  • 52 Week High $183.98
  • 52 Week Low $96.24
  • 50 Day Moving Average 152.16
  • 200 Day Moving Average 158.57
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Ascendis Pharma A/S (ASND) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Ascendis Pharma A/S (ASND) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-10$535000-$3.15-$1.87-68.17%
2020-09-302020-11-11$2.76 million-$2.72-$1.87-45.17%
2020-06-302020-08-27$1.44 million-$2.33-$1.61-44.68%
2020-03-312020-05-19$2.23 million-$1.44-$1.41-2.66%
2019-12-312019-12-31$2.51 million-$1.89-$1.62-16.67%
2019-09-302019-11-18$2.44 million-$0.59-$1.2954.34%
2019-06-302019-08-28$3.62 million-$1.38-$1.33-4.4%
2019-03-312019-05-30$6.07 million-$1.38-$1.14-20.89%
2018-12-312018-12-31$12.06 million-$0.86-$1.1424.56%
2018-09-302018-11-28$23153.51-$0.92-$1.1922.87%
2018-06-302018-08-29$20949.72-$0.64-$1.0035.45%
2018-03-312018-05-30$34444.58-$1.25-$0.88-41.8%
2017-12-312018-03-28$362000-$1.13-$0.99-14.12%
2017-09-302017-11-16$546000-$1.22-$0.86-42.4%
2017-06-302017-08-18$533000-$1.11-$0.88-26.09%
2017-03-312017-05-23$398000-$0.87-$0.76-15.03%
2016-12-312017-03-22$855000-$0.55-$0.7122.7%
2016-09-302016-11-30$1.36 million-$0.76-$0.64-19.56%
2016-06-302016-08-31$1.21 million-$0.59-$0.658.96%
2016-03-312016-04-14$1.43 million-$0.59-$0.30-95.13%
2015-09-302015-11-12$2.37 million-$0.29-$0.5648.21%
2015-06-302015-08-24$2.25 million-$0.63-$0.43-46.51%
2015-03-312015-05-18$2.24 million$0.07-$0.39117.95%
2014-12-312015-01-28$2.83 million-$0.65

Ascendis Pharma A/S (ASND) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Ascendis Pharma A/S (ASND) Chart:

Ascendis Pharma A/S (ASND) News:

Below you will find a list of latest news for Ascendis Pharma A/S (ASND) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Ascendis Pharma A/S (ASND) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-17750CALL0 0160.92TRUE00
2024-05-17800CALL0 0157.81TRUE00
2024-05-17850CALL0 0158.23TRUE00
2024-05-17900CALL0 0161.07TRUE00
2024-05-17950CALL0 0150.82TRUE00
2024-05-1710051CALL0 16147.51TRUE00
2024-05-171050CALL0 0143.91TRUE00
2024-05-171100CALL0 0138.14TRUE00
2024-05-1711537.72CALL0 6132.37TRUE00
2024-05-1712033.74CALL0 1123.67TRUE00
2024-05-171250CALL0 0119.31TRUE00
2024-05-1713029CALL0 5114.81TRUE00
2024-05-1713525.4CALL0 12108.74TRUE00
2024-05-1714014.63CALL15 1594.31TRUE14.630
2024-05-1714517CALL0 21496.02FALSE00
2024-05-1715014CALL0 31788.62FALSE00
2024-05-1715514.19CALL0 11082.22FALSE00
2024-05-171604.63CALL15 100373.05FALSE4.630
2024-05-171655.5CALL1 106569.57FALSE5.50
2024-05-171709.7CALL0 365.73FALSE00
2024-05-171751.75CALL1 32068.71FALSE-1.1-0.39
2024-05-171801.75CALL2 174.6FALSE1.750
2024-05-171853.01CALL0 690FALSE00
2024-05-171902.61CALL0 430FALSE00
2024-05-171952CALL0 250FALSE00
2024-05-172004.1CALL0 10FALSE00
2024-05-172100CALL0 00FALSE00
2024-05-172200CALL0 00FALSE00
2024-05-172300CALL0 00FALSE00
2024-05-17752.94PUT0 1188.02FALSE00
2024-05-17803.7PUT0 2169.9FALSE00
2024-05-17850PUT0 0166.94FALSE00
2024-05-17900PUT0 0156.3FALSE00
2024-05-17956.1PUT0 76152.57FALSE00
2024-05-171004.9PUT10 30144.69FALSE4.90
2024-05-171050PUT0 0134.74FALSE00
2024-05-171106.8PUT18 0135.21FALSE6.80
2024-05-171157.7PUT4 1128.52FALSE7.70
2024-05-171208.9PUT9 68123.46FALSE8.90
2024-05-171255.4PUT0 5120.36FALSE00
2024-05-1713011.9PUT13 137114.49FALSE-0.9-0.07
2024-05-1713513.4PUT9 228108.18FALSE-1-0.07
2024-05-1714015PUT10 428101.3FALSE150
2024-05-1714516.5PUT1 992.35TRUE16.50
2024-05-1715016PUT0 188.95TRUE00
2024-05-1715519.7PUT0 582.93TRUE00
2024-05-171600PUT0 073.93TRUE00
2024-05-171650PUT0 065.8TRUE00
2024-05-171700PUT0 059.43TRUE00
2024-05-171750PUT0 053.15TRUE00
2024-05-171800PUT0 085.12TRUE00
2024-05-171850PUT0 091.17TRUE00
2024-05-171900PUT0 096.93TRUE00
2024-05-171950PUT0 0102.44TRUE00
2024-05-172000PUT0 0107.72TRUE00
2024-05-172100PUT0 0117.68TRUE00
2024-05-172200PUT0 0126.94TRUE00
2024-05-172300PUT0 0135.61TRUE00
2024-06-21450CALL0 0123.12TRUE00
2024-06-21500CALL0 0123.7TRUE00
2024-06-21550CALL0 0110.42TRUE00
2024-06-21600CALL0 0119.41TRUE00
2024-06-21650CALL0 0120.84TRUE00
2024-06-217045CALL0 1119.41TRUE00
2024-06-21750CALL0 0122.78TRUE00
2024-06-21800CALL0 0122.09TRUE00
2024-06-21850CALL0 0118.5TRUE00
2024-06-21900CALL0 0116.9TRUE00
2024-06-21950CALL0 0114.29TRUE00
2024-06-2110053CALL0 263109.5TRUE00
2024-06-211050CALL0 0105.33TRUE00
2024-06-2111023.24CALL0 6101.59TRUE00
2024-06-2111525.9CALL0 197.58TRUE00
2024-06-211200CALL0 094.63TRUE00
2024-06-2112516.79CALL0 2288.03TRUE00
2024-06-2113029.3CALL0 685.12TRUE00
2024-06-2113521CALL0 1280.35TRUE00
2024-06-2114021CALL20 3277.56TRUE210
2024-06-2114518.9CALL0 173.73FALSE00
2024-06-2115017.8CALL0 29269.66FALSE00
2024-06-2115513.77CALL0 965.9FALSE00
2024-06-211609.58CALL1 2470.47FALSE9.580
2024-06-2116511.3CALL0 2459.42FALSE00
2024-06-2117010CALL0 1156.66FALSE00
2024-06-211755.6CALL0 1050.92FALSE00
2024-06-211806CALL0 5355.42FALSE00
2024-06-211857.03CALL0 358.32FALSE00
2024-06-211905CALL0 650FALSE00
2024-06-211953.5CALL0 7365.6FALSE00
2024-06-212000CALL0 00FALSE00
2024-06-212100CALL0 00FALSE00
2024-06-212200CALL0 00FALSE00
2024-06-212300CALL0 00FALSE00
2024-06-21450.25PUT0 10FALSE00
2024-06-21500.6PUT0 20FALSE00
2024-06-21551.3PUT0 70FALSE00
2024-06-21600PUT0 0158.06FALSE00
2024-06-21650PUT0 0145.67FALSE00
2024-06-21703.5PUT0 2133.86FALSE00
2024-06-21750PUT0 0122.88FALSE00
2024-06-21801PUT0 0118.07FALSE00
2024-06-21851.37PUT0 6119.43FALSE00
2024-06-21900PUT0 0118.3FALSE00
2024-06-21952.28PUT0 15115.68FALSE00
2024-06-211008.99PUT0 1225110.37FALSE00
2024-06-211057PUT1 0101.48FALSE70
2024-06-211107.4PUT0 759103.41FALSE00
2024-06-211152.9PUT0 1498.94FALSE00
2024-06-211209.4PUT0 54993.22FALSE00
2024-06-2112510PUT0 1890.11FALSE00
2024-06-2113011.9PUT0 383.49FALSE00
2024-06-2113513.4PUT0 379.6FALSE00
2024-06-211409PUT0 577.41FALSE00
2024-06-2114516PUT0 373.9TRUE00
2024-06-2115018.9PUT0 28368.83TRUE00
2024-06-2115518.8PUT0 566.43TRUE00
2024-06-2116021.4PUT0 263.38TRUE00
2024-06-2116527.4PUT0 261.71TRUE00
2024-06-211700PUT0 055.67TRUE00
2024-06-2117537.7PUT0 154.59TRUE00
2024-06-211800PUT0 050.16TRUE00
2024-06-211850PUT0 048.67TRUE00
2024-06-211900PUT0 047.28TRUE00
2024-06-211950PUT0 071.63TRUE00
2024-06-212000PUT0 075.29TRUE00
2024-06-212100PUT0 082.2TRUE00
2024-06-212200PUT0 088.65TRUE00
2024-06-212300PUT0 094.69TRUE00
2024-07-19500CALL0 089.16TRUE00
2024-07-19550CALL0 0103.15TRUE00
2024-07-19600CALL0 0105.64TRUE00
2024-07-196544CALL0 1104.93TRUE00
2024-07-19700CALL0 0102.66TRUE00
2024-07-19750CALL0 0105.14TRUE00
2024-07-19800CALL0 0103.53TRUE00
2024-07-19850CALL0 0100.22TRUE00
2024-07-199025.5CALL0 1100.77TRUE00
2024-07-19950CALL0 096.26TRUE00
2024-07-191000CALL0 095.07TRUE00
2024-07-191050CALL0 091.25TRUE00
2024-07-191100CALL0 087.85TRUE00
2024-07-191150CALL0 084.29TRUE00
2024-07-191200CALL0 081.86TRUE00
2024-07-1912539CALL0 11278.91TRUE00
2024-07-1913031CALL0 574.67TRUE00
2024-07-1913531CALL0 373.24TRUE00
2024-07-1914032.97CALL0 468.76TRUE00
2024-07-1914523CALL0 167.73FALSE00
2024-07-1915017.5CALL0 863.31FALSE00
2024-07-1915516.2CALL0 761.8FALSE00
2024-07-1916014.8CALL0 2460.28FALSE00
2024-07-191650CALL0 056.83FALSE00
2024-07-1917014CALL0 1755.84FALSE00
2024-07-191750CALL0 054.05FALSE00
2024-07-191800CALL0 052.98FALSE00
2024-07-1918511.25CALL0 152.65FALSE00
2024-07-191900CALL0 051.32FALSE00
2024-07-191950CALL0 051.4FALSE00
2024-07-192006.7CALL0 1156.81FALSE00
2024-07-192100CALL0 00FALSE00
2024-07-192200CALL0 00FALSE00
2024-07-192300CALL0 00FALSE00
2024-07-19500.25PUT0 10FALSE00
2024-07-19550.9PUT0 10FALSE00
2024-07-19600PUT0 0132.04FALSE00
2024-07-19650PUT0 0121.41FALSE00
2024-07-19700PUT0 0112.21FALSE00
2024-07-19750PUT0 0107.63FALSE00
2024-07-19800PUT0 0103.73FALSE00
2024-07-19850PUT0 0102.51FALSE00
2024-07-19903.8PUT0 5100.73FALSE00
2024-07-19950PUT0 098.86FALSE00
2024-07-191007.5PUT0 9094.88FALSE00
2024-07-191054.55PUT0 194.58FALSE00
2024-07-191103.06PUT0 189.5FALSE00
2024-07-191156.3PUT0 587.94FALSE00
2024-07-191207.41PUT0 182.28FALSE00
2024-07-1912510.1PUT0 178.89FALSE00
2024-07-1913011.5PUT0 175.84FALSE00
2024-07-1913513.9PUT0 671.69FALSE00
2024-07-1914015.1PUT0 168.7FALSE00
2024-07-1914514.8PUT0 268.53TRUE00
2024-07-1915017PUT0 965.29TRUE00
2024-07-1915519.7PUT0 163.14TRUE00
2024-07-1916022.6PUT0 260.95TRUE00
2024-07-191650PUT0 059.08TRUE00
2024-07-191700PUT0 057.54TRUE00
2024-07-191750PUT0 056.2TRUE00
2024-07-191800PUT0 055.11TRUE00
2024-07-191850PUT0 052.71TRUE00
2024-07-191900PUT0 050.24TRUE00
2024-07-191950PUT0 046.91TRUE00
2024-07-192000PUT0 047.36TRUE00
2024-07-192100PUT0 070.76TRUE00
2024-07-192200PUT0 076.28TRUE00
2024-07-192300PUT0 081.45TRUE00
2024-10-18750CALL0 086.19TRUE00
2024-10-18800CALL0 084.85TRUE00
2024-10-18850CALL0 084.01TRUE00
2024-10-189071.6CALL0 181.43TRUE00
2024-10-18950CALL0 079.47TRUE00
2024-10-181000CALL0 078.38TRUE00
2024-10-181050CALL0 076.12TRUE00
2024-10-181100CALL0 073.26TRUE00
2024-10-181150CALL0 071.18TRUE00
2024-10-181200CALL0 068.83TRUE00
2024-10-181250CALL0 067.69TRUE00
2024-10-181300CALL0 064.78TRUE00
2024-10-181350CALL0 061.91TRUE00
2024-10-181400CALL0 061.69TRUE00
2024-10-181450CALL0 059.78FALSE00
2024-10-181500CALL0 059.06FALSE00
2024-10-181550CALL0 056.08FALSE00
2024-10-1816021.2CALL0 254.89FALSE00
2024-10-1816519.8CALL0 055.12FALSE00
2024-10-181700CALL0 053.19FALSE00
2024-10-181750CALL0 054.59FALSE00
2024-10-181800CALL0 053FALSE00
2024-10-181850CALL0 051.43FALSE00
2024-10-181900CALL0 051.67FALSE00
2024-10-181950CALL0 051.03FALSE00
2024-10-182000CALL0 050.55FALSE00
2024-10-182100CALL0 049.32FALSE00
2024-10-182200CALL0 048.87FALSE00
2024-10-182300CALL0 049.84FALSE00
2024-10-18750PUT0 087.86FALSE00
2024-10-18800PUT0 085.31FALSE00
2024-10-18850PUT0 084.78FALSE00
2024-10-18900PUT0 082.23FALSE00
2024-10-18956.1PUT0 1081.12FALSE00
2024-10-181005.69PUT0 577.8FALSE00
2024-10-181050PUT0 075.27FALSE00
2024-10-181100PUT0 074.21FALSE00
2024-10-181150PUT0 070.98FALSE00
2024-10-1812012.4PUT0 669.42FALSE00
2024-10-1812511.5PUT0 2067.81FALSE00
2024-10-181300PUT0 064.75FALSE00
2024-10-181350PUT0 062.67FALSE00
2024-10-1814017.2PUT0 562.24FALSE00
2024-10-181450PUT0 061.28TRUE00
2024-10-181500PUT0 059.18TRUE00
2024-10-181550PUT0 057.86TRUE00
2024-10-181600PUT0 057.04TRUE00
2024-10-181650PUT0 055.96TRUE00
2024-10-181700PUT0 054.86TRUE00
2024-10-181750PUT0 054.18TRUE00
2024-10-181800PUT0 053.5TRUE00
2024-10-181850PUT0 052.38TRUE00
2024-10-181900PUT0 051.14TRUE00
2024-10-181950PUT0 050.3TRUE00
2024-10-182000PUT0 050.59TRUE00
2024-10-182100PUT0 049.23TRUE00
2024-10-182200PUT0 047.35TRUE00
2024-10-182300PUT0 062.83TRUE00
2024-12-20450CALL0 074.8TRUE00
2024-12-20500CALL0 078.38TRUE00
2024-12-20550CALL0 076.3TRUE00
2024-12-20600CALL0 076.72TRUE00
2024-12-20650CALL0 077.44TRUE00
2024-12-20700CALL0 076.32TRUE00
2024-12-20750CALL0 075.79TRUE00
2024-12-20800CALL0 075.11TRUE00
2024-12-20850CALL0 072.78TRUE00
2024-12-20900CALL0 071.68TRUE00
2024-12-20950CALL0 069.45TRUE00
2024-12-201000CALL0 068.92TRUE00
2024-12-201050CALL0 066.21TRUE00
2024-12-201100CALL0 066.67TRUE00
2024-12-201150CALL0 065.24TRUE00
2024-12-2012048.9CALL0 364.21TRUE00
2024-12-2012545.6CALL0 363.15TRUE00
2024-12-2013042.5CALL0 361.2TRUE00
2024-12-2013539.5CALL0 159.98TRUE00
2024-12-2014040.2CALL0 058.73TRUE00
2024-12-201450CALL0 058.13FALSE00
2024-12-2015029.35CALL0 156.91FALSE00
2024-12-201550CALL0 056.31FALSE00
2024-12-2016024.25CALL0 154.46FALSE00
2024-12-2016527.8CALL0 053.65FALSE00
2024-12-201700CALL0 053.24FALSE00
2024-12-2017515CALL3 37454.04FALSE150
2024-12-201800CALL0 050.98FALSE00
2024-12-2018515.95CALL0 150.36FALSE00
2024-12-201900CALL0 050.21FALSE00
2024-12-2019513CALL0 2049.71FALSE00
2024-12-2020013CALL0 2049.23FALSE00
2024-12-202100CALL0 047.96FALSE00
2024-12-202200CALL0 048.18FALSE00
2024-12-202300CALL0 048.09FALSE00
2024-12-20450PUT0 00FALSE00
2024-12-20500PUT0 00FALSE00
2024-12-20550PUT0 088.92FALSE00
2024-12-20600PUT0 081.86FALSE00
2024-12-20650PUT0 078.1FALSE00
2024-12-20700PUT0 075.37FALSE00
2024-12-20750PUT0 075.89FALSE00
2024-12-20800PUT0 074.52FALSE00
2024-12-20850PUT0 074.51FALSE00
2024-12-20900PUT0 070.48FALSE00
2024-12-20950PUT0 071.5FALSE00
2024-12-201008.1PUT0 1570.98FALSE00
2024-12-201055PUT0 268.63FALSE00
2024-12-201100PUT0 067.14FALSE00
2024-12-2011510.9PUT0 665.93FALSE00
2024-12-2012012.5PUT0 364.97FALSE00
2024-12-2012514.5PUT0 1664.2FALSE00
2024-12-2013016.1PUT0 262.28FALSE00
2024-12-2013519.4PUT0 660.36FALSE00
2024-12-201400PUT0 059.81FALSE00
2024-12-2014522.4PUT0 258.96TRUE00
2024-12-201500PUT0 056.7TRUE00
2024-12-201550PUT0 057.05TRUE00
2024-12-201600PUT0 055.78TRUE00
2024-12-201650PUT0 054.86TRUE00
2024-12-201700PUT0 053.66TRUE00
2024-12-201750PUT0 051.9TRUE00
2024-12-201800PUT0 052.97TRUE00
2024-12-201850PUT0 051.49TRUE00
2024-12-201900PUT0 050.96TRUE00
2024-12-201950PUT0 049.87TRUE00
2024-12-202000PUT0 049.88TRUE00
2024-12-202100PUT0 049.01TRUE00
2024-12-202200PUT0 047.51TRUE00
2024-12-202300PUT0 047.24TRUE00
2025-01-17450CALL0 071.59TRUE00
2025-01-17500CALL0 071.35TRUE00
2025-01-17550CALL0 073.49TRUE00
2025-01-17600CALL0 072.6TRUE00
2025-01-17650CALL0 073.24TRUE00
2025-01-17700CALL0 072.76TRUE00
2025-01-17750CALL0 071.61TRUE00
2025-01-17800CALL0 070TRUE00
2025-01-178559.2CALL0 069.37TRUE00
2025-01-179024.5CALL0 166.72TRUE00
2025-01-179551.5CALL0 065.75TRUE00
2025-01-171000CALL0 066.06TRUE00
2025-01-171050CALL0 064.04TRUE00
2025-01-171100CALL0 064.11TRUE00
2025-01-171150CALL0 063.23TRUE00
2025-01-1712047.01CALL0 2262.32TRUE00
2025-01-1712547.5CALL0 2161.01TRUE00
2025-01-1713032.8CALL0 160.17TRUE00
2025-01-1713536.8CALL0 1958.84TRUE00
2025-01-1714039.3CALL0 3858.27TRUE00
2025-01-1714529CALL0 1057.44FALSE00
2025-01-1715034.5CALL0 1756.05FALSE00
2025-01-1715527.3CALL0 2555.48FALSE00
2025-01-171600CALL0 054.87FALSE00
2025-01-171650CALL0 052.99FALSE00
2025-01-171700CALL0 052.33FALSE00
2025-01-171750CALL0 051.32FALSE00
2025-01-171800CALL0 050.72FALSE00
2025-01-171850CALL0 049.88FALSE00
2025-01-171900CALL0 049.59FALSE00
2025-01-171950CALL0 049.09FALSE00
2025-01-172000CALL0 048.26FALSE00
2025-01-1721011CALL0 1046.87FALSE00
2025-01-172208CALL0 1046.96FALSE00
2025-01-172307.5CALL0 7548.15FALSE00
2025-01-17451.5PUT0 20FALSE00
2025-01-17500PUT0 00FALSE00
2025-01-17550PUT0 084.51FALSE00
2025-01-17600PUT0 077.82FALSE00
2025-01-17650PUT0 071.51FALSE00
2025-01-17700PUT0 072.31FALSE00
2025-01-17753.2PUT0 2071.8FALSE00
2025-01-17800PUT0 072.08FALSE00
2025-01-17850PUT0 071.34FALSE00
2025-01-17900PUT0 068.83FALSE00
2025-01-179515.25PUT0 37566.89FALSE00
2025-01-171000PUT0 068.26FALSE00
2025-01-1710518PUT0 166.01FALSE00
2025-01-171100PUT0 063.73FALSE00
2025-01-171150PUT0 063.55FALSE00
2025-01-171200PUT0 062.49FALSE00
2025-01-1712515.75PUT0 161.65FALSE00
2025-01-171300PUT0 060.17FALSE00
2025-01-1713519.1PUT0 060.48FALSE00
2025-01-1714024.5PUT0 2958.17FALSE00
2025-01-171450PUT0 057.79TRUE00
2025-01-171500PUT0 057.56TRUE00
2025-01-171550PUT0 057.17TRUE00
2025-01-171600PUT0 054.93TRUE00
2025-01-171650PUT0 054.11TRUE00
2025-01-171700PUT0 052.7TRUE00
2025-01-171750PUT0 052.85TRUE00
2025-01-171800PUT0 052.39TRUE00
2025-01-171850PUT0 050.75TRUE00
2025-01-171900PUT0 050.34TRUE00
2025-01-171950PUT0 049.82TRUE00
2025-01-1720060.3PUT0 16149.27TRUE00
2025-01-1721068.73PUT0 10148.25TRUE00
2025-01-172200PUT0 048.13TRUE00
2025-01-172300PUT0 047.04TRUE00
2025-06-20500CALL0 064.85TRUE00
2025-06-20550CALL0 065.68TRUE00
2025-06-20600CALL0 065.32TRUE00
2025-06-20650CALL0 064.31TRUE00
2025-06-207046CALL0 162.9TRUE00
2025-06-20750CALL0 063.29TRUE00
2025-06-20800CALL0 063.06TRUE00
2025-06-20850CALL0 061.58TRUE00
2025-06-209075.4CALL0 160.67TRUE00
2025-06-20950CALL0 060.21TRUE00
2025-06-2010026CALL0 159.58TRUE00
2025-06-201050CALL0 058.46TRUE00
2025-06-201100CALL0 057.83TRUE00
2025-06-201150CALL0 057.96TRUE00
2025-06-2012043.5CALL0 356.47TRUE00
2025-06-201250CALL0 056.24TRUE00
2025-06-201300CALL0 055.31TRUE00
2025-06-2013548CALL0 054.69TRUE00
2025-06-201400CALL0 053.89TRUE00
2025-06-2014511.4CALL0 153.8FALSE00
2025-06-2015037CALL0 352.68FALSE00
2025-06-2015536.7CALL0 252.26FALSE00
2025-06-201600CALL0 051.26FALSE00
2025-06-2016518.93CALL0 250.95FALSE00
2025-06-201700CALL0 050.07FALSE00
2025-06-201750CALL0 049.05FALSE00
2025-06-201800CALL0 048.29FALSE00
2025-06-201850CALL0 047.39FALSE00
2025-06-2019018.5CALL0 146.76FALSE00
2025-06-201950CALL0 046.42FALSE00
2025-06-202000CALL0 045.94FALSE00
2025-06-202100CALL0 044.57FALSE00
2025-06-202200CALL0 044.05FALSE00
2025-06-202300CALL0 043.04FALSE00
2025-06-20500PUT0 00FALSE00
2025-06-20550PUT0 00FALSE00
2025-06-20600PUT0 063.14FALSE00
2025-06-20650PUT0 063.84FALSE00
2025-06-20700PUT0 063.77FALSE00
2025-06-20750PUT0 063.1FALSE00
2025-06-20800PUT0 062.05FALSE00
2025-06-20850PUT0 060.7FALSE00
2025-06-209011.3PUT0 060.64FALSE00
2025-06-20950PUT0 060.18FALSE00
2025-06-201000PUT0 059.41FALSE00
2025-06-2010511PUT0 059FALSE00
2025-06-201100PUT0 058.31FALSE00
2025-06-201150PUT0 057.92FALSE00
2025-06-2012016PUT0 256.18FALSE00
2025-06-2012518.5PUT0 056.46FALSE00
2025-06-201300PUT0 055.91FALSE00
2025-06-201350PUT0 055.15FALSE00
2025-06-201400PUT0 054.66FALSE00
2025-06-201450PUT0 053.98TRUE00
2025-06-201500PUT0 053.12TRUE00
2025-06-201550PUT0 052.5TRUE00
2025-06-201600PUT0 051.71TRUE00
2025-06-201650PUT0 051.16TRUE00
2025-06-201700PUT0 050.44TRUE00
2025-06-201750PUT0 049.5TRUE00
2025-06-201800PUT0 049.25TRUE00
2025-06-201850PUT0 048.4TRUE00
2025-06-201900PUT0 048.26TRUE00
2025-06-201950PUT0 047.37TRUE00
2025-06-202000PUT0 047.29TRUE00
2025-06-2021064.8PUT0 26946.04TRUE00
2025-06-202200PUT0 045.58TRUE00
2025-06-202300PUT0 044.6TRUE00

Latest ASND Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$79.93
Jun 13, 2022 7:59 PM EST4$79.91
Jun 13, 2022 7:59 PM EST118$79.93
Jun 13, 2022 7:59 PM EST9$79.97
Jun 13, 2022 7:59 PM EST17$79.97

Ascendis Pharma A/S (ASND) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520185199/0001193125-20-185199-index.htm
2019-06-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000008025519002847/0000080255-19-002847-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000008025520001284/0000080255-20-001284-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000031506620000822/0000315066-20-000822-index.htm
2019-03-12SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787119000203/0000947871-19-000203-index.htm
2019-08-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787119000594/0000947871-19-000594-index.htm
2020-03-05SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000185/0000947871-20-000185-index.htm
2020-05-08SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000446/0000947871-20-000446-index.htm
2020-05-22SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000511/0000947871-20-000511-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920021751/0001104659-20-021751-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920021912/0001104659-20-021912-index.htm
2020-09-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920103962/0001104659-20-103962-index.htm
2019-02-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519042416/0001193125-19-042416-index.htm
2019-03-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519059442/0001193125-19-059442-index.htm
2019-03-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519061604/0001193125-19-061604-index.htm
2019-03-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519062499/0001193125-19-062499-index.htm
2019-03-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519065750/0001193125-19-065750-index.htm
2019-03-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519069120/0001193125-19-069120-index.htm
2019-03-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519074983/0001193125-19-074983-index.htm
2019-04-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519096618/0001193125-19-096618-index.htm
2019-04-0320-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519096759/0001193125-19-096759-index.htm
2019-04-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519105316/0001193125-19-105316-index.htm
2019-04-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519112380/0001193125-19-112380-index.htm
2019-05-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519133019/0001193125-19-133019-index.htm
2019-05-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519149447/0001193125-19-149447-index.htm
2019-05-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519161327/0001193125-19-161327-index.htm
2019-05-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519161365/0001193125-19-161365-index.htm
2019-06-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519173846/0001193125-19-173846-index.htm
2019-06-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519175289/0001193125-19-175289-index.htm
2019-06-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519181943/0001193125-19-181943-index.htm
2019-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519187411/0001193125-19-187411-index.htm
2019-07-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519191873/0001193125-19-191873-index.htm
2019-07-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519196527/0001193125-19-196527-index.htm
2019-08-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519221217/0001193125-19-221217-index.htm
2019-08-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519232458/0001193125-19-232458-index.htm
2019-09-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519244911/0001193125-19-244911-index.htm
2019-09-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519255970/0001193125-19-255970-index.htm
2019-10-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519263919/0001193125-19-263919-index.htm
2019-10-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519265843/0001193125-19-265843-index.htm
2019-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519292336/0001193125-19-292336-index.htm
2019-11-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519293431/0001193125-19-293431-index.htm
2019-11-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519294735/0001193125-19-294735-index.htm
2019-12-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519312728/0001193125-19-312728-index.htm
2020-01-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520002169/0001193125-20-002169-index.htm
2020-01-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520005786/0001193125-20-005786-index.htm
2020-01-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520008093/0001193125-20-008093-index.htm
2020-02-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520033240/0001193125-20-033240-index.htm
2020-03-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520071551/0001193125-20-071551-index.htm
2020-03-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520092940/0001193125-20-092940-index.htm
2020-04-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520094591/0001193125-20-094591-index.htm
2020-04-0320-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520096870/0001193125-20-096870-index.htm
2020-04-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520108208/0001193125-20-108208-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520111593/0001193125-20-111593-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520112279/0001193125-20-112279-index.htm
2020-04-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520126717/0001193125-20-126717-index.htm
2020-05-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520133706/0001193125-20-133706-index.htm
2020-05-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520142982/0001193125-20-142982-index.htm
2020-05-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520146167/0001193125-20-146167-index.htm
2020-06-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520157336/0001193125-20-157336-index.htm
2020-06-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520167815/0001193125-20-167815-index.htm
2020-06-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520180048/0001193125-20-180048-index.htm
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520185199/0001193125-20-185199-index.htm
2020-07-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520187456/0001193125-20-187456-index.htm
2020-07-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520187810/0001193125-20-187810-index.htm
2020-07-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520190428/0001193125-20-190428-index.htm
2020-07-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520191149/0001193125-20-191149-index.htm
2020-07-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520194325/0001193125-20-194325-index.htm
2020-08-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520219118/0001193125-20-219118-index.htm
2020-08-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520233148/0001193125-20-233148-index.htm
2020-09-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520241091/0001193125-20-241091-index.htm
2020-09-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520243078/0001193125-20-243078-index.htm
2020-09-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520252366/0001193125-20-252366-index.htm
2020-09-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520257235/0001193125-20-257235-index.htm
2020-09-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520257292/0001193125-20-257292-index.htm
2020-10-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520263856/0001193125-20-263856-index.htm
2020-10-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000119312520265872/0001193125-20-265872-index.htm
2020-10-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520270385/0001193125-20-270385-index.htm
2020-10-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520275018/0001193125-20-275018-index.htm
2019-10-23SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000121390019020915/0001213900-19-020915-index.htm
2019-02-22CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1612042/999999999719000498/9999999997-19-000498-index.htm
2020-07-15CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1612042/999999999720004106/9999999997-20-004106-index.htm